We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.97%
2 Consumer Discretionary 10.47%
3 Healthcare 9.98%
4 Financials 9.67%
5 Industrials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBT
1626
DELISTED
Welbilt, Inc.
WBT
$70K ﹤0.01%
11,411
– –
ALEX
1627
DELISTED
Alexander & Baldwin
ALEX
$69K ﹤0.01%
6,134
– –
ARCB icon
1628
ArcBest
ARCB
$3.19B
$69K ﹤0.01%
2,213
– –
CELH icon
1629
Celsius Holdings
CELH
$7.36B
$69K ﹤0.01%
9,105
– –
LNTH icon
1630
Lantheus
LNTH
$6.59B
$69K ﹤0.01%
5,452
– –
NBHC icon
1631
National Bank Holdings
NBHC
$1.94B
$69K ﹤0.01%
2,643
– –
NCLH icon
1632
Norwegian Cruise Line
NCLH
$8.73B
$69K ﹤0.01%
4,050
– –
PGNY icon
1633
Progyny
PGNY
$2.02B
$69K ﹤0.01%
2,328
– –
QNCX icon
1634
Quince Therapeutics
QNCX
$34.6M
$69K ﹤0.01%
7
– –
RCKT icon
1635
Rocket Pharmaceuticals
RCKT
$381M
$69K ﹤0.01%
3,009
– –
SCHG icon
1636
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
$69K ﹤0.01%
4,816
– –
SPNS
1637
DELISTED
Sapiens International
SPNS
$69K ﹤0.01%
2,264
– –
UNFI icon
1638
United Natural Foods
UNFI
$2.93B
$69K ﹤0.01%
4,650
– –
NBL
1639
DELISTED
Noble Energy, Inc.
NBL
$69K ﹤0.01%
8,122
– –
FRO icon
1640
Frontline
FRO
$9.17B
$68K ﹤0.01%
10,421
– –
NXC
1641
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
$68K ﹤0.01%
4,262
– –
SBSI icon
1642
Southside Bancshares
SBSI
$986M
$68K ﹤0.01%
2,786
– –
FMTX
1643
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$68K ﹤0.01%
+1,373
New +$55.5K
RAVN
1644
DELISTED
Raven Industries Inc
RAVN
$68K ﹤0.01%
3,174
– –
FIZZ icon
1645
National Beverage
FIZZ
$2.93B
$67K ﹤0.01%
1,978
– –
NHC icon
1646
National Healthcare
NHC
$3.5B
$67K ﹤0.01%
1,074
– –
PLOW icon
1647
Douglas Dynamics
PLOW
$976M
$67K ﹤0.01%
1,952
– –
PSN icon
1648
Parsons
PSN
$5.12B
$67K ﹤0.01%
1,992
– –
TSM icon
1649
TSMC
TSM
$2.21T
$67K ﹤0.01%
827
+142
+21% +$10.8K
CBB
1650
DELISTED
Cincinnati Bell Inc.
CBB
$67K ﹤0.01%
4,444
– –
64 65
66
67 68

Similar funds

AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.